ARDIZZONI, ANDREA
ARDIZZONI, ANDREA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Docenti di ruolo di Ia fascia
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series
2016-01-01 Graziani, Tiziano; Ceci, Francesco; Castellucci, Paolo; Polverari, Giulia; Lima, Giacomo Maria; Lodi, Filippo; Morganti, Alessio Giuseppe; Ardizzoni, Andrea; Schiavina, Riccardo; Fanti, Stefano
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series
2016-01-01 Graziani, Tiziano; Ceci, Francesco; Castellucci, Paolo; Polverari, Giulia; Lima, Giacomo Maria; Lodi, Filippo; Morganti, Alessio Giuseppe; Ardizzoni, Andrea; Schiavina, Riccardo; Fanti, Stefano
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
2016-01-01 Ceci, F; Castellucci, P; Graziani, T; Schiavina, R; Renzi, R; Borghesi, M; Di Tullio, P; Brunocilla, E; Ardizzoni, A; Fanti, S
18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results
2016-01-01 G Polverari, V Ambrosini, F Gelsomino, S Diodato, F Ceci, F Sperandi, A Ardizzoni, S Fanti
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC)
2018-01-01 Morgensztern, Daniel*; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E.; Lewanski, Conrad R.; Bennouna, Jaafar; Fischer, Jürgen R.; Juan-Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C.; Jin Ong, Teng; Govindan, Ramaswamy
Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer
2011-01-01 Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini EM; Guazzi A; Ardizzoni A
ACTIVITY AND SAFETY OF DOSE-ADJUSTED INFUSIONAL CHOP CHEMOTHERAPY WITH RITUXIMAB (DA-POCH-R) IN VERY ELDERLY PATIENTS WITH POOR-PROGNOSTIC UNTREATED DIFFUSE LARGE B-CELL NON-HODGKIN'S LYMPHOMA
2010-01-01 Boggiani D; Musolino A; Panebianco M; Franciosi V; Vasini G; Salvagni S; Ardizzoni A
Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma
2011-01-01 Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma
2021-01-01 Di Federico A.; Filippini D.M.; Sperandi F.; Ardizzoni A.; Melotti B.
Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer
2019-01-01 Livi, Vanina; Ardizzoni, Andrea; Cancellieri, Alessandra; Natali, Filippo; Ferrari, Marco; Paioli, Daniela; De Biase, Dario; Capizzi, Elisa; Tallini, Giovanni; Fiorentino, Michelangelo; Trisolini, Rocco
Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study
2015-01-01 Barni, Sandro; Maiello, Evaristo; Di Maio, Massimo; Ardizzoni, Andrea; Cappuzzo, Federico; Maranzano, Ernesto; Novello, Silvia; Bennati, Chiara; Ori, Alessandra; Rizzoli, Sara; Crinò, Lucio
Adjuvant chemotherapy for non-small cell lung cancer: Ready for clinical practice?
2006-01-01 Tiseo M; Franciosi V; Grossi F; Ardizzoni A
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study
2014-01-01 Gridelli, Cesare; de Marinis, Filippo; Ardizzoni, Andrea; Novello, Silvia; Fontanini, Gabriella; Cappuzzo, Federico; Grossi, Francesco; Santo, Antonio; Cortinovis, Diego; Favaretto, Adolfo; Lorusso, Vito; Galetta, Domenico; Siena, Salvatore; Bettini, Anna; Iurlaro, Monica; Caprioli, Alberto; LIFE study team, Null
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): An open-label randomised controlled phase 3 trial
2015-01-01 Soria, Jean-Charles; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Li, Wei; Isla, Dolores; Guclu, Salih Z.; Morabito, Alessandro; Min, Young J.; Ardizzoni, Andrea; Gadgeel, Shirish M.; Wang, Bushi; Chand, Vikram K.; Goss, Glenwood D.
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial
2021-01-01 Goss G.D.; Cobo M.; Lu S.; Syrigos K.; Lee K.H.; Goker E.; Georgoulias V.; Isla D.; Morabito A.; Min Y.J.; Ardizzoni A.; Bender S.; Cseh A.; Felip E.
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients
2015-01-01 Bozzetti, Cecilia; Nizzoli, Rita; Tiseo, Marcello; Squadrilli, Anna; Lagrasta, Costanza; Buti, Sebastiano; Gasparro, Donatello; Zanoni, Daniele; Majori, Maria; De Filippo, Massimo; Mazzoni, Francesca; Maddau, Cristina; Naldi, Nadia; Sammarelli, Gabriella; Frati, Caterina; Pinto, Carmine; Ardizzoni, Andrea
ALK rearrangement testing by fish analysis in non-small-cell lung cancer patients: Results of the first Italian external quality assurance scheme
2014-01-01 Marchetti, Antonio; Barberis, Massimo; Papotti, Mauro; Rossi, Giulio; Franco, Renato; Malatesta, Sara; Buttitta, Fiamma; Ardizzoni, Andrea; Crinò, Lucio; Gridelli, Cesare; Taddei, Gian Luigi; Clemente, Claudio; Scagliotti, Giorgio; Normanno, Nicola; Pinto, Carmine
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience
2020-01-01 Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F.
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding
2018-01-01 Dall'Olio, Filippo Gustavo; Sperandi, Francesca; Rihawi, Karim; Gargiulo, Mauro; Melotti, Barbara; Brocchi, Stefano; Gelsomino, Francesco*; Ardizzoni, Andrea
ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic NonâSmall Cell Lung Cancer (NSCLC)
2017-01-01 Cho, Byoung Chul*; Kim, Dong-Wan; Bearz, Alessandra; Laurie, Scott A.; McKeage, Mark; Borra, Gloria; Park, Keunchil; Kim, Sang-We; Ghosn, Marwan; Ardizzoni, Andrea; Maiello, Evaristo; Greystoke, Alastair; Yu, Richard; Osborne, Karen; Gu, Wen; Scott, Jeffrey W.; Passos, Vanessa Q.; Lau, Yvonne Y.; Wrona, Anna
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series | Graziani, Tiziano; Ceci, Francesco; Castellucci, Paolo; Polverari, Giulia; Lima, Giacomo Maria; Lodi, Filippo; Morganti, Alessio Giuseppe; Ardizzoni, Andrea; Schiavina, Riccardo; Fanti, Stefano | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| 11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series | Graziani, Tiziano; Ceci, Francesco; Castellucci, Paolo; Polverari, Giulia; Lima, Giacomo Maria; Lodi, Filippo; Morganti, Alessio Giuseppe; Ardizzoni, Andrea; Schiavina, Riccardo; Fanti, Stefano | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| 11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel | Ceci, F; Castellucci, P; Graziani, T; Schiavina, R; Renzi, R; Borghesi, M; Di Tullio, P; Brunocilla, E; Ardizzoni, A; Fanti, S | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| 18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results | G Polverari, V Ambrosini, F Gelsomino, S Diodato, F Ceci, F Sperandi, A Ardizzoni, S Fanti | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 4.02 Riassunto (Abstract) | - |
| ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC) | Morgensztern, Daniel*; Cobo, Manuel; Ponce Aix, Santiago; Postmus, Pieter E.; Lewanski, Conrad R.; Bennouna, Jaafar; Fischer, Jürgen R.; Juan-Vidal, Oscar; Stewart, David J.; Fasola, Gianpiero; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Talbot, Denis C.; Jin Ong, Teng; Govindan, Ramaswamy | 2018-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer | Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini EM; Guazzi A; Ardizzoni A | 2011-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| ACTIVITY AND SAFETY OF DOSE-ADJUSTED INFUSIONAL CHOP CHEMOTHERAPY WITH RITUXIMAB (DA-POCH-R) IN VERY ELDERLY PATIENTS WITH POOR-PROGNOSTIC UNTREATED DIFFUSE LARGE B-CELL NON-HODGKIN'S LYMPHOMA | Boggiani D; Musolino A; Panebianco M; Franciosi V; Vasini G; Salvagni S; Ardizzoni A | 2010-01-01 | ANNALS OF ONCOLOGY | - | 1.06 Abstract in rivista | - |
| Activity and Safety of Dose-Adjusted Infusional Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Chemotherapy With Rituximab in Very Elderly Patients With Poor-Prognostic Untreated Diffuse Large B-Cell Non-Hodgkin Lymphoma | Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A | 2011-01-01 | CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Acute kidney injury as a possible immune-related adverse event associated with sustained complete response to BRAF and MEK inhibitors in advanced, V600E-mutated melanoma | Di Federico A.; Filippini D.M.; Sperandi F.; Ardizzoni A.; Melotti B. | 2021-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Adequacy of endosonography-derived samples from peribronchial or periesophageal intrapulmonary lesions for the molecular profiling of lung cancer | Livi, Vanina; Ardizzoni, Andrea; Cancellieri, Alessandra; Natali, Filippo; Ferrari, Marco; Paioli, Daniela; De Biase, Dario; Capizzi, Elisa; Tallini, Giovanni; Fiorentino, Michelangelo; Trisolini, Rocco | 2019-01-01 | THE CLINICAL RESPIRATORY JOURNAL | - | 1.01 Articolo in rivista | - |
| Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study | Barni, Sandro; Maiello, Evaristo; Di Maio, Massimo; Ardizzoni, Andrea; Cappuzzo, Federico; Maranzano, Ernesto; Novello, Silvia; Bennati, Chiara; Ori, Alessandra; Rizzoli, Sara; Crinò, Lucio | 2015-01-01 | LUNG CANCER | - | 1.01 Articolo in rivista | - |
| Adjuvant chemotherapy for non-small cell lung cancer: Ready for clinical practice? | Tiseo M; Franciosi V; Grossi F; Ardizzoni A | 2006-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study | Gridelli, Cesare; de Marinis, Filippo; Ardizzoni, Andrea; Novello, Silvia; Fontanini, Gabriella; Cappuzzo, Federico; Grossi, Francesco; Santo, Antonio; Cortinovis, Diego; Favaretto, Adolfo; Lorusso, Vito; Galetta, Domenico; Siena, Salvatore; Bettini, Anna; Iurlaro, Monica; Caprioli, Alberto; LIFE study team, Null | 2014-01-01 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): An open-label randomised controlled phase 3 trial | Soria, Jean-Charles; Felip, Enriqueta; Cobo, Manuel; Lu, Shun; Syrigos, Konstantinos; Lee, Ki Hyeong; Göker, Erdem; Georgoulias, Vassilis; Li, Wei; Isla, Dolores; Guclu, Salih Z.; Morabito, Alessandro; Min, Young J.; Ardizzoni, Andrea; Gadgeel, Shirish M.; Wang, Bushi; Chand, Vikram K.; Goss, Glenwood D. | 2015-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung: Final analysis of the randomised phase 3 LUX-Lung 8 trial | Goss G.D.; Cobo M.; Lu S.; Syrigos K.; Lee K.H.; Goker E.; Georgoulias V.; Isla D.; Morabito A.; Min Y.J.; Ardizzoni A.; Bender S.; Cseh A.; Felip E. | 2021-01-01 | ECLINICALMEDICINE | - | 1.01 Articolo in rivista | main.pdf; ScienceDirect_files_28Jun2022_13-33-03.749.zip |
| ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients | Bozzetti, Cecilia; Nizzoli, Rita; Tiseo, Marcello; Squadrilli, Anna; Lagrasta, Costanza; Buti, Sebastiano; Gasparro, Donatello; Zanoni, Daniele; Majori, Maria; De Filippo, Massimo; Mazzoni, Francesca; Maddau, Cristina; Naldi, Nadia; Sammarelli, Gabriella; Frati, Caterina; Pinto, Carmine; Ardizzoni, Andrea | 2015-01-01 | DIAGNOSTIC CYTOPATHOLOGY | - | 1.01 Articolo in rivista | - |
| ALK rearrangement testing by fish analysis in non-small-cell lung cancer patients: Results of the first Italian external quality assurance scheme | Marchetti, Antonio; Barberis, Massimo; Papotti, Mauro; Rossi, Giulio; Franco, Renato; Malatesta, Sara; Buttitta, Fiamma; Ardizzoni, Andrea; Crinò, Lucio; Gridelli, Cesare; Taddei, Gian Luigi; Clemente, Claudio; Scagliotti, Giorgio; Normanno, Nicola; Pinto, Carmine | 2014-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience | Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F. | 2020-01-01 | EXPERT OPINION ON BIOLOGICAL THERAPY | - | 1.01 Articolo in rivista | - |
| Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding | Dall'Olio, Filippo Gustavo; Sperandi, Francesca; Rihawi, Karim; Gargiulo, Mauro; Melotti, Barbara; Brocchi, Stefano; Gelsomino, Francesco*; Ardizzoni, Andrea | 2018-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.01 Articolo in rivista | - |
| ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic NonâSmall Cell Lung Cancer (NSCLC) | Cho, Byoung Chul*; Kim, Dong-Wan; Bearz, Alessandra; Laurie, Scott A.; McKeage, Mark; Borra, Gloria; Park, Keunchil; Kim, Sang-We; Ghosn, Marwan; Ardizzoni, Andrea; Maiello, Evaristo; Greystoke, Alastair; Yu, Richard; Osborne, Karen; Gu, Wen; Scott, Jeffrey W.; Passos, Vanessa Q.; Lau, Yvonne Y.; Wrona, Anna | 2017-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.01 Articolo in rivista | - |